3 news items
Rhythm Pharmaceuticals Receives Positive Recommendation from NICE for ▼IMCIVREE® (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl Syndrome
RYTM
22 May 24
with this positive recommendation from NICE, made possible by the collaboration and support of advocacy leaders at BBS U.K. and clinical experts, and engaging
Analyst Expectations For Rhythm Pharmaceuticals's Future
RYTM
26 Apr 24
.
Understanding Analyst Ratings: A Comprehensive Breakdown
The perception of Rhythm Pharmaceuticals by financial experts
5 Analysts Assess Rhythm Pharmaceuticals: What You Need To Know
RYTM
10 Apr 24
Analyst Ratings: A Comprehensive Breakdown
A clear picture of Rhythm Pharmaceuticals's perception among financial experts is painted
- Prev
- 1
- Next